An accurate, sensitive, precise and rapid gradient reversed-phase high-performance liquid chromatographic method was successfully developed and validated for the determination of doxycycline hyclate in bulk drug and tablets. The best separation was achieved on a 250 3 4.6 mm, 5.0 mm particle size CN Luna column with water 1 0.1% TFA -acetonitrile 1 0.1% TFA, 60:40 (v/v) as the mobile phase at a flow rate of 1.0 mL/min. Ultraviolet detection was performed at 360 nm at ambient column temperature (258 8 8 8 8C). The method was linear over the concentration range of 50-100 mg/mL (r 5 0.9999) with limits of detection and quantification of 2.83 and 8.59 mg/mL, respectively. The drug was subjected to oxidation, acid, base and neutral degradation, photolysis and heat as stress conditions. Degradation products were found interfering with the assay of doxycycline hyclate, therefore the method can be regarded as suitable. The method was applied for the determination of doxycycline hyclate in standard and pharmaceutical products, with excellent recoveries. The method can be used for the quality control of doxycycline hyclate.
is the hydrochloride hemiethanol hemihydrate of doxycycline (DOX). DOXH is much more soluble than doxycycline monohydrate, which is one of the primary reasons for its more frequent use in pharmaceutical samples (1) .
The functional groups corresponding to its pKa values are shown in Figure 2 (2) .
DOXH is a semisynthetic broad spectrum tetracycline antibiotic, widely used in veterinary medicine and as an animal feed supplement to prevent diseases (3) . It has been studied as an inhibitor of matrix metalloproteinases (intercellular substance), an action unrelated to its effects on bacterial protein synthesis (4, 5) .
DOXH is more active than tetracycline against many bacterial species, including Streptococcus pyogenes, enterococci, Nocardia spp and several anaerobic species (6) . DOXH is preferred to other tetracyclines in the treatment of specific infections because of its fairly reliable absorption and its long half-life, which permits less frequent dosage. It is frequently used to treat chronic prostatitis, sinusitis, syphilis, chlamdydia and pelvic inflammatory disease (1) . It has action against protozoa and must be administered in combination with quinine in the management of chloroquine resistant Plasmodium falciparum (6) . Solutions of DOXH are also used for malignant effusions (7) that are often associated with malignancies and lymphomas of the lung, breast and ovary (6) .
A liquid chromatography method for the determination of DOXH is the choice of some pharmacopoeias (8, 9, 10) . High-performance liquid chromatography (HPLC) has also been applied for the determination of DOX and DOXH in samples of liver and muscle tissue (11) , turkey plasma (12), milk (13) , medicated premixes for incorporation into medicated feed (3), pharmaceuticals (14) and bulk powders, tablets and human urine (1) .
On a timeline, if the mobile phases and columns of the previously used methods are compared (3, 15) , it is clear that the preparation time has improved, and methods are becoming more dynamic and easier to prepare. Regarding the running time of DOX, comparing the studied methods (3, 16) shows that there was a decrease from more than 30 to 12 min. Comparing the mobile phases shows a trend toward researching methods of analysis that require quick and easy handling of reagents and preparation time, which has improved the ease, without losing the parameters of linearity, selectivity, precision, accuracy and robustness of the analysis.
As an alternative to the existing methods, the aim of this study was to develop, validate and apply an inexpensive, useful and simple HPLC-ultraviolet (UV) method for quantitative determination of DOXH in tablets. Table I shows some methods for determination of DOX in biological fluids and dosage forms.
Experimental

Instrumentation and reagents
Materials and standards HPLC grade acetonitrile (J.T. Baker, Phillipsburg, NJ), HPLC grade trifluoroacetic acid (Halocarbon, EUA) and analytical reagent grade hydrochloric acid (J.T. Baker, Me´xico) were used. Deionized Milli Q water (Millipore, Bedford, MA) was used to prepare the mobile phase and diluent solutions. DOXH standard and tablets were supplied by Unia˜o Quı´mica Indu´stria Farmaceˆutica (Pouso Alegre, Brasil). The mobile phase was prepared by mixing water þ 0.1 % TFA and acetonitrile þ 0.1 % TFA in the ratio 60:40 (v/v), and filtering through 0.45 micron membrane filter. Diluent was 1 Â 10 22 mol/L of hydrochloric acid. A stock standard solution equivalent to 200 mg/mL DOXH was prepared by dissolving an accurately weighed amount of pure drug in the diluent solution.
Equipment
HPLC analysis was performed on a Waters HPLC system equipped with a Waters 1525 binary gradient chromatography pump, a Rheodyne Breeze 7725i manual injector and a Waters 2487 ultraviolet-visible (UV-Vis) detector.
Chromatographic conditions
Chromatographic analysis was conducted at ambient temperature (258C) on a CN Luna column (250 Â 4.6 mm, 5.0 mm particle size). The mobile phase was a mixture of water þ 0.1 % TFA and acetonitrile þ 0.1 % TFA (60:40, v/v). The flow rate was 1.0 mL/min. The detector wavelength was set at 360 nm, with injection volume at 20 mL.
Pharmaceutical preparations
Twenty tablets were accurately weighed, crushed into a fine powder and mixed using a mortar and pestle. A quantity of tablet powder equivalent to 80 mg of DOXH was weighed accurately into a 100 mL calibrated flask; 50 mL of diluent solution was added and the mixture was sonicated for 5 min to complete dissolution of the DOXH; the mixture was then diluted to the mark with the diluent and mixed well. A small portion of the resulting mixture was withdrawn and filtered through a 0.45 mm filter to ensure the absence of particulate matter. The filtrate was appropriately diluted with the diluent before injection onto the column.
Methods
Method validation
Method validation was performed following International Conference on Harmonization (ICH) specifications (25) for linearity, selectivity, accuracy, precision, robustness, detection limit and quantitation limit.
Linearity
Linearity was evaluated by regression analysis. Twenty microliters of working standard solutions (50-100 mg/mL DOXH) were manually injected onto the column in triplicate and the chromatograms were recorded. The equation of the line was determined by linear regression analysis by the method of least squares. The areas used in determining the calibration curve were statistically evaluated by analysis of variance (ANOVA).
Selectivity
Selectivity was evaluated by a forced degradation procedure. DOXH solutions were prepared in 1 Â 10 21 mol/L HCl, 1 Â 10 21 mol/L NaOH, 3% H 2 O 2 and H 2 O at a concentration of 80 mg/mL, and all four solutions were kept in a hot water bath at 608C. Aliquots of these solutions were taken at 30, 90, and 180 min, and 24 and 48 h and analyzed immediately by the HPLC method. Additionally, a solution of DOXH was prepared in water at a concentration of 80 mg/mL and submitted to UV light. Aliquots of this solution were taken at 3, 6 and 24 h and analyzed immediately by the HPLC method.
Accuracy
The accuracy of the method was determined by measuring the reference standard recovery in triplicate at three levels from 80 to 120% of the method concentration (80 mg/mL), according to ICH recommendations. A standard stock solution containing 200 mg/mL of DOXH was prepared in 1 Â 10 22 mol/L of hydrochloric acid. In volumetric flasks of 10 mL, aliquots of 300, 1,500 and 2,300 mL of this standard solution (concentrations of 1.5, 7.5 and 11.5 mg/mL, respectively) were individually added to 2,500 mL of sample solutions at 200 mg/mL (concentration of 50 mg/mL). The final concentrations were 64, 80 and 96 mg/mL, which correspond to 80, 100 and 120% of the target concentration, respectively. The mean recoveries, expressed in terms of percent recovery of the tablets (Doxitrat 80 mg) of the assay and the relative standard deviation (RSD), were determined.
Precision
Precision was evaluated with respect to both repeatability and intermediate precision. Repeatability was evaluated by analyzing DOXH working standard solutions at the same concentration and during the same day. Intermediate precision was studied by repetition of the assays on two different days by two analysts. Six replicates at a concentration of 80 mg/mL were prepared and assayed. The data were analyzed at 360 nm. The RSD percentages of the analytical responses were calculated.
Robustness
The robustness of the method was evaluated by analyzing data after determining the levels of acetonitrile, wavelength and rate of the mobile phase. DOXH working standard solutions at the concentration of 80 mg/mL were used in these experiments.
Limits of detection and quantification
The limit of detection (LOD) and limit of quantification (LOQ) of the method were obtained from Equations (1) and (2):
where SD is the standard deviation of the intersection and a is the average slope, obtained from calibration curves of the linearity study.
Assay of pharmaceutical products
The validated HPLC -UV method was applied for the quantitation of DOXH in tablets (80 mg Doxitrat tablets). The results were obtained by comparing the measurements of the sample solutions (n ¼ 6) with those obtained from DOXH standard solutions (n ¼ 6) at the same concentration levels.
Results and Discussion
Method validation
The analytical parameters of linearity, specificity, LOD, LOQ, precision, accuracy and robustness were evaluated to validate the method, according to ICH recommendations (25) .
Linearity
A working standard solution of DOXH (200 mg/mL) was appropriately diluted with the diluent solution to obtain solutions in the concentration range of 50 -100 mg/mL DOXH. Twenty microliters of each solution were injected in triplicate into the column under the previously described operating chromatographic conditions. The equation of the line, determined by the method of least squares, is y ¼ 25378x -54442, with a correlation coefficient (r) greater than 0.9999. HPLC Column containing C18 packing and maintained at 608C. Mobile phase: 2.72 g of potassium phosphate monobasic, 0.74 g of NaOH, 0.50 g of tetrabutylammonium hydrogen sulfate and 0.40 g of sodium edetate to 1,000 mL of water, with the addition of 60 g of tertiary butyl alcohol with the pH adjusted to 8 using 1 mol/L NaOH. NI UV at 270 nm Standard (10) *NI: not informed.
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The data were validated by means of ANOVA (Table II) , which showed significant linear regression (F calculated .F critical , P ¼ 5%) and no significant lack of fit (F calculated ,F critical , P ¼ 5%). Figure 3 shows the overlap of the chromatograms of the DOXH standard and the sample with a retention time of 4.45 min.
LOD and LOQ
The results of the LOD and LOQ were 2.83 and 8.59 mg/mL, respectively, for 80 mg Doxitrat tablets. The values are low, which indicates the sensitivity of the method.
Specificity
The specificity of the method was checked by comparing the chromatograms obtained for pure DOXH solution in the forced degradation procedure. The specificity of the method can be determined with the addition of impurities and degradation products, obtained experimentally or by inducing their formation (26) . The DOXH tablets were subjected to degradation in acidic, alkaline, oxidative, watery and photolytic media. Decreases occurred in all absolute peak areas of doxycycline hyclate, confirming the qualitative specificity (Figures 4 and 5) . These forced degradation studies show the susceptibility of the drug against degradation in acidic, basic, oxidative and photolytic media. This suggests that the method has specificity and can be used in stability studies.
Precision
The repeatability (intra-day precision) of the analytical method was found to be reliable based on RSD (,2%). Intermediate precision (inter-day precision) was demonstrated on different days by two analysts. The RSD values were less than 2%, confirming that the method is sufficiently precise (Table III) .
Accuracy
The accuracy of the method was confirmed by determining the average recoveries from the samples by applying the standard addition method. As shown in Table IV , the mean percentage recoveries of the 80 mg Doxitrat product were found in accordance with the fixed limits of 98.0 to 102.0%, indicating the suitability of the developed method in quantifying the concentration of DOXH in pharmaceutical tablets.
Robustness
The mean of variations in brand of acetonitrile, wavelength and rate of the mobile phase to evaluate the robustness parameters was statistically analyzed; the result is shown in Table V . Assay of pharmaceutical products The validated method was applied for the determination of DOXH in tablets. Samples from 80 mg Doxitrat tablet were analyzed. The results, expressed as percentage of drug related, are shown in Table VI .
Conclusions
In this work, an analytical HPLC -UV method was developed for the quantitative determination of DOXH in tablets. Its advantages over other existing method include its simplicity, speed and low cost. The results indicated that the developed HPLC-UV method has good linearity, selectivity, accuracy, precision and robustness and adequate detection and quantification limits. Therefore, the validated method can be easily applied in the routine analysis of DOXH. 
